drug
viloxazine hydrochloride ER
Marketedupdated 3mo agoby $SUPN SUPERNUS PHARMACEUTICALS, INC.
Approvedcommunity read0 votes
all catalysts(0)
nothing on the calendar yet
Patent cliff
source: FDA Orange Bookfirst barrier falls
Sep 4, 2029
~3.1 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (18)
- Apr 2, 2035formulationUS 9662338
- Apr 2, 2035formulationUS 9662338
- Apr 2, 2035formulationUS 9662338
- Feb 7, 2033formulationUS 9358204
- Feb 7, 2033formulationUS 9358204
- Feb 7, 2033formulationUS 9358204
- Feb 7, 2033method-of-use (U-727)US 9603853
- Feb 7, 2033method-of-use (U-727)US 9603853
- Feb 7, 2033method-of-use (U-727)US 9603853
- Sep 4, 2029method-of-use (U-727)US 113247533.1y
- Sep 4, 2029method-of-use (U-727)US 113247533.1y
- Sep 4, 2029method-of-use (U-727)US 113247533.1y
- Sep 4, 2029method-of-use (U-727)US 114581433.1y
- Sep 4, 2029method-of-use (U-727)US 114581433.1y
- Sep 4, 2029method-of-use (U-727)US 114581433.1y
- Sep 4, 2029method-of-use (U-727)US 121215233.1y
- Sep 4, 2029method-of-use (U-727)US 121215233.1y
- Sep 4, 2029method-of-use (U-727)US 121215233.1y
FDA exclusivities (3)
- Apr 2, 2026NCENew Chemical Entity (5y)
- Apr 2, 2026NCENew Chemical Entity (5y)
- Apr 2, 2026NCENew Chemical Entity (5y)
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 57m ago
Found something off?
comments(0)
5-min edit window · permanent after that